L-NAME and L-arginine differentially ameliorate cigarette smoke-induced emphysema in mice

Samuel Santos Valença1, Carlos Romualdo Rueff-Barroso, Wagner Alves Pimenta

  • 1Institute of Biomedical Science, Federal University of Rio de Janeiro, Brazil. samuelv@ufrj.br

Insights

Nitric oxide (NO) inhibition or supplementation, along with N-acetylcysteine (NAC), protected mouse lungs from cigarette smoke (CS) damage. NAC offered the most significant protection, suggesting complex roles for NO and oxidative stress in emphysema.

Area of Science:

  • Pulmonary Medicine
  • Biochemistry
  • Pharmacology

Background:

  • Nitric oxide (NO) is a key mediator in biological and pathological processes.
  • Pulmonary emphysema, often induced by cigarette smoke (CS), involves complex inflammatory and oxidative pathways.
  • Understanding NO's role is crucial for developing effective emphysema treatments.

Purpose of the Study:

  • To investigate the therapeutic effects of inhibiting or supplementing nitric oxide (NO) in a mouse model of cigarette smoke-induced pulmonary emphysema.
  • To compare the protective effects of an NO inhibitor (L-NAME), an NO substrate (L-arginine), and N-acetylcysteine (NAC) against CS-induced lung injury.

Main Methods:

  • Pulmonary emphysema was induced in mice using cigarette smoke (CS).
  • Mice were treated with L-NAME (NO inhibitor), L-arginine (NO substrate), or N-acetylcysteine (NAC).
  • Bronchoalveolar lavage, lung histology, and biochemical analyses were performed to assess lung injury, inflammation, oxidative stress, and protease/antiprotease balance.

Main Results:

  • CS exposure significantly increased neutrophil counts and oxidative stress in mouse lungs.
  • L-NAME and L-arginine treatments reduced neutrophil counts and offered lung protection compared to CS alone, but did not fully restore lung health.
  • NAC treatment demonstrated superior protection against CS-induced lung injury compared to L-NAME and L-arginine, with reduced oxidative stress.
  • CS-induced increases in tissue inhibitors of metalloproteinase 1 and 2 were observed, particularly with L-NAME and L-arginine treatment.

Conclusions:

  • Both NO inhibition and supplementation show protective effects in CS-induced emphysema, indicating NO's complex role.
  • N-acetylcysteine (NAC) provides significant lung protection, potentially through mechanisms beyond direct NO modulation.
  • Effective treatment may involve balancing protease-antiprotease and oxidant-antioxidant systems in the lung.